Osteoporosis International

Journal

Publication Venue For

  • Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.  31:1283-1290. 2020
  • Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017.  31:1299-1304. 2020
  • Correction to: Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures (Osteoporosis International, (2020), 31, 1, (1-12), 10.1007/s00198-019-05176-3).  31:797-798. 2020
  • Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.  31. 2020
  • Glucocorticoid-induced osteoporosis: 2019 concise clinical review.  30:1145-1156. 2019
  • Sex differences in osteoporosis self-efficacy among community-residing older adults presenting for DXA.  30:1033-1041. 2019
  • Recommendations for the conduct of economic evaluations in osteoporosis: outcomes of an experts’ consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the US branch of the International Osteoporosis Foundation.  30:45-57. 2019
  • Risk of subsequent fracture after prior fracture among older women.  30:79-92. 2019
  • Correction to: Hip fracture trends in the United States, 2002 to 2015 (Osteoporosis International, (2018), 29, 3, (717-722), 10.1007/s00198-017-4345-0).  29:2583. 2018
  • Dietary patterns and longitudinal change in hip bone mineral density among older men.  29:1135-1145. 2018
  • The epidemiology of wrist fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.  29:859-870. 2018
  • Hip fracture trends in the United States, 2002 to 2015.  29:717-722. 2018
  • High dairy protein intake is associated with greater bone strength parameters at the distal radius and tibia in older men: a cross-sectional study.  29:69-77. 2018
  • Self-perception of fracture risk: what can it tell us?.  28:3495-3500. 2017
  • Validity, reliability, and responsiveness to change of the “Osteoporosis and You” knowledge scale.  28:3379-3388. 2017
  • The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation.  28:3283-3284. 2017
  • The cost of a patient activation intervention for achieving successful outcomes: results from the PAADRN randomized controlled trial.  28:3061-3066. 2017
  • The effects of a patient activation intervention on smoking and excessive drinking cessations: results from the PAADRN randomized controlled trial.  28:3055-3060. 2017
  • Erratum to: Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study (Osteoporosis International, (2017), 28, 8, (2495-2503), 10.1007/s00198-017-4073-5).  28:2505. 2017
  • Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.  1-9. 2017
  • The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.  28:1225-1232. 2017
  • Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial.  27:3513-3524. 2016
  • Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.  27:3239-3249. 2016
  • The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials.  27:2655-2671. 2016
  • Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men.  27:2291-2300. 2016
  • The effects of state-level expenditures for home- and community-based services on the risk of becoming a long-stay nursing home resident after hip fracture.  27:953-961. 2016
  • Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance).  26:1971-1977. 2015
  • Underdevelopment of trabecular bone microarchitecture in the distal femur of nonambulatory children with cerebral palsy becomes more pronounced with distance from the growth plate..  26:505-512. 2015
  • The effect of a 3-month moderate-intensity physical activity program on body composition in overweight and obese African American college females.  25:2485-2491. 2014
  • An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database.  26:581-587. 2014
  • Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.  25:85-95. 2014
  • International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study.  26:419-420. 2014
  • The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group.  25:1439-1443. 2014
  • Use of pharmacologic agents for the primary prevention of osteoporosis among older women with low bone mass.  25:317-324. 2014
  • Multimodal intervention to improve osteoporosis care in home health settings: Results from a cluster randomized trial.  24:2555-2560. 2013
  • Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan.  24:1195-1206. 2013
  • Performance of FRAX in a cohort of community-dwelling, ambulatory older men: The Osteoporotic Fractures in Men (MrOS) study.  24:1185-1193. 2013
  • Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: The Study of Osteoporotic Fractures and Medicare claims data.  24:801-810. 2013
  • Non-hip, non-spine fractures drive healthcare utilization following a fracture: The Global Longitudinal Study of Osteoporosis in Women (GLOW).  24:59-67. 2013
  • Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: The Global Longitudinal study of Osteoporosis in Women (GLOW).  23:2863-2871. 2012
  • Acknowledgments for "best practices in systems-based interventions to reduce the burden of fractures" (Osteoporosis International Volume 22, Supplement 3, August 2011).  23:2393-2394. 2012
  • Defining physiologically "normal" vitamin D in African Americans.  23:2283-2291. 2012
  • Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: The Global Longitudinal Study of Osteoporosis in Women.  23:2179-2188. 2012
  • The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.  23:2141-2150. 2012
  • Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis.  23:1083-1090. 2012
  • Improving osteoporosis care through multimodal interventions: Insights from the University of Alabama at Birmingham Center for Education and Research on Therapeutics.  22. 2011
  • Systems-based approaches to osteoporosis and fracture care: Policy and research recommendations from the workgroups.  22. 2011
  • Medical costs of osteoporosis in the elderly Medicare population.  22:1835-1844. 2011
  • Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey.  22:1745-1753. 2011
  • Ethnic differences in femur geometry in the women's health initiative observational study.  22:1377-1388. 2011
  • Erratum: Clinical and demographic factors associated with fractures among older Americans (Osteoporosis International DOI: 10.1007/s00198-010-1300-8).  22:1275-1276. 2011
  • Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men.  22:1079-1090. 2011
  • An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis.  22:305-315. 2011
  • Clinical and demographic factors associated with fractures among older Americans.  22:1263-1274. 2011
  • Failure to perceive increased risk of fracture in women 55 years and older: The Global Longitudinal Study of Osteoporosis in Women (GLOW).  22:27-35. 2011
  • Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis.  21:1573-1584. 2010
  • Hip structural geometry and incidence of hip fracture in postmenopausal women: What does it add to conventional bone mineral density?.  21:919-929. 2010
  • "pathologic" fractures: Should these be included in epidemiologic studies of osteoporotic fractures?.  20:1969-1972. 2009
  • Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research.  20:1921-1927. 2009
  • Estimated prevalence and patterns of presumed osteoporosis among older Americans based on Medicare data.  20:1507-1515. 2009
  • The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States.  20:1553-1561. 2009
  • The Global Longitudinal Study of Osteoporosis in Women (GLOW): Rationale and study design.  20:1107-1116. 2009
  • RisedronatE and ALendronate intervention over three years (REALITY): Minimal differences in fracture risk reduction.  20:973-978. 2009
  • Vertebroplasty and kyphoplasty are associated with an increased risk of secondary vertebral compression fractures: A population-based cohort study.  20:819-826. 2009
  • Risk of hip fracture after bisphosphonate discontinuation: Implications for a drug holiday.  19:1613-1620. 2008
  • Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture.  18:553-559. 2007
  • Endogenous sex steroids, weight change and rates of hip bone loss in older men: The MrOS study.  17:1329-1336. 2006
  • Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users.  17:1268-1274. 2006
  • Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.  17:61-67. 2006
  • Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment.  16:1545-1557. 2005
  • Oral contraceptives and bone mineral density in white and black women in CARDIA.  13:893-900. 2002
  • Mapping of quantitative ultrasound of the calcaneus bone to chromosome 1 by genome-wide linkage analysis.  13:796-802. 2002
  • International Standard Serial Number (issn)

  • 0937-941X
  • Electronic International Standard Serial Number (eissn)

  • 1433-2965